Evolving MSC: Appointing new CEO
We have some exciting news here in the MSC team. Co-founder Tobias Thornblad is handing over the CEO torch to Julia Fransson. While Tobias will still be present in the role as Chair of MSC, Julia will take the helm starting early 2022.
Read full post >
January 18, 2022
Biotech valuation courses
Our valuation courses aim to guide you through the basic mechanics of biotech valuation and provide benchmark data and references that may serve as assumptions about key factors. Our goal has been to create something actionable for CEOs, business developers, board members and investors in small biotech companies to use when preparing negotiations for financing rounds or business deals.
Read more >
We understand the business issues facing smaller biotech companies and share a passion with our clients to drive the future of medicine.
We support leaders with actionable recommendations and insights with a fervor and razor-sharp focus. Our approach is doing so by creating tailored solutions to challenging business issues and crafting strategies to achieve business goals and brand visibility. Whether it is business development, asset valuation or communication, we are a reliable partner that always walk that extra mile.